Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02921009 · ClinicalTrials.gov registry record · NA
McNeel Eye Center Corneal Crosslinking Study
A NA study of Keratoconus, sponsored by McNeel Eye Center.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02921009 is a NA study of Keratoconus that is active but no longer recruiting, run by McNeel Eye Center. The registered enrollment target is 100 participants, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02921009, a NA study of Keratoconus, is active but no longer recruiting, sponsored by McNeel Eye Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.
Conditions Studied
Interventions
- DEVICE Crosslinking using UV light of two different fluence rates
Study Locations (1)
Idaho
- McNeel Eye Center - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02921009
The ClinicalTrials.gov registry entry for NCT02921009 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,176-participant average among 21 other Keratoconus trials with a reported enrollment target (91% lower). The listed sponsor is McNeel Eye Center, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Crosslinking using UV light of two different fluence rates is the first listed.
NCT02921009 reports 1 study location spanning 1 distinct geographic area - top geographies include Idaho.
Frequently Asked Questions
What is clinical trial NCT02921009 about?
NCT02921009 is a clinical study titled "McNeel Eye Center Corneal Crosslinking Study". This study will investigate the effectiveness in treating keratoconus, pellucid marginal degeneration and post LASIK iatrogenic ectasia utilizing fluence rates and treatment times of Corneal Cross Linking other than the original FDA approved protocol of 3mw/cm2.
What is the current status of trial NCT02921009?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2016-09-01. Estimated completion is 2025-12-31.
What conditions does trial NCT02921009 study?
This clinical trial studies the following conditions: Keratoconus.
What interventions are being tested in trial NCT02921009?
The interventions under investigation include: Crosslinking using UV light of two different fluence rates (DEVICE).
Who is sponsoring clinical trial NCT02921009?
This trial is sponsored by McNeel Eye Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02921009 being conducted?
This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Intacs Prescription Inserts for Keratoconus Patients
RECRUITING · NA
-
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism
ACTIVE NOT RECRUITING · NA
-
Initial Correction Keratoconus
ACTIVE NOT RECRUITING · NA
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
OCT in Diagnosis of Irregular Corneas
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.